Colon cancer survivors are more likely to have pain in the back and abdomen

June 27, 2014
Manuel Arroyo-Morales. Credit: UGRdivulga

Researchers from the University of Granada have discovered that colon cancer survivors are more likely to suffer future lesions related with pain in the back and lower abdomen than healthy individuals of the same gender and age.

These patients present a series of abnormalities in the abdominal wall architecture—the site of surgery in oncological treatment. Moreover, they have specific abnormalities in processing that may increase their sensitization to any kind of pain in the future.

In two articles published in Pain Medicine and the European Journal of Cancer Care, University of Granada researchers from the Department of Physical Therapy analyse the physical and of colon cancer patients following oncological treatment. The study—funded by the Campus of International Excellence: BioHealth and Information & Communications Technology (CEI BioTic)—was conducted in collaboration with researchers from the Department of Surgery of the Hospital Clínico San Cecilio, Granada.

Third most frequent type of cancer

As principal author, Manuel Arroyo-Morales explains, "colon cancer is the third most common cancer in the world if we consider both genders together. Thanks to advances in oncological treatment, the chances of survival have risen spectacularly in recent years—between 44% and 65% in the last 5 years. This improvement in treatment has led to the appearance of a group of people who have had cancer and have managed to overcome it".

However, oncological treatment is extremely tough physically and highly traumatic psychologically. "The fact that this group of wrongly termed 'cancer survivors' should be growing leads us to ask what price they have to pay for their survival", says this University of Granada researcher.

The results indicate that when we compare these patients with individuals of a similar age and gender, we find that colon present a substantial deterioration of their functional capacity—that is, their capacity to lead normal daily work and leisure routines.

Loss of strength

This deterioration in functional capacity is due to their loss of physical condition because of physical rest during the treatment and convalescence that they have to undergo for several months. "The loss of parameters like muscle strength in the back or cardiorespiratory capacity can mean up to a 60% deterioration by comparison with healthy individuals of the same gender and age".

At the same time, colon cancer patients have symptoms like fatigue or moderate tiredness due to the illness itself. "All these physical abnormalities impact on their quality of life to the extent that this can be reduced by around 40% when compared with individuals of the same age and gender not affected by cancer", says Arroyo.

The University of Granada research group's next objective is to conduct physiotherapy programmes aimed at improving these physical issues and, thus, help patients regain quality of life.

Explore further: Depression and pain increase fatigue in breast cancer survivors

Related Stories

Depression and pain increase fatigue in breast cancer survivors

September 14, 2011
In Spain, 5-year survival following breast cancer diagnosis is more than 83%. Around 66% suffer fatigue following treatment. A Spanish research establishes the factors associated with tiredness in cancer survivors to improve ...

New research sheds light on racial disparity in colon cancer

June 23, 2014
African-Americans with colon cancer are half as likely as Caucasian patients to have a type of colon cancer that is linked to better outcomes. The finding may provide insight into why African-Americans are more likely to ...

New study could improve survival rate of colon cancer patients

March 6, 2014
A unique trial at Queen's University could improve the survival rate of patients with colon cancer. This is the first study to test if exercise can improve the cure rate of colon cancer and improve quality of life and physical ...

Radiation therapy for cervical cancer increases risk for colorectal cancer

April 17, 2014
Researchers at the University of Texas Medical Branch at Galveston are the first to recommend that young women treated with radiation for cervical cancer should begin colorectal cancer screening earlier than traditionally ...

New report estimates nearly 19 million cancer survivors in the US by 2024

June 1, 2014
The number of cancer survivors in the United States, currently estimated to be 14.5 million, will grow to almost 19 million by 2024, according to an updated report by the American Cancer Society. The second edition of Cancer ...

Diets high in dairy might boost colon cancer survival, a bit

June 24, 2014
(HealthDay)—A diet rich in dairy products may slightly extend the lives of people diagnosed with colon cancer, a new study suggests.

Recommended for you

New findings explain how UV rays trigger skin cancer

October 18, 2017
Melanoma, a cancer of skin pigment cells called melanocytes, will strike an estimated 87,110 people in the U.S. in 2017, according to the Centers for Disease Control and Prevention. A fraction of those melanomas come from ...

Drug yields high response rates for lung cancer patients with harsh mutation

October 18, 2017
A targeted therapy resurrected by the Moon Shots Program at The University of Texas MD Anderson Cancer Center has produced unprecedented response rates among patients with metastatic non-small cell lung cancer that carries ...

Possible new immune therapy target in lung cancer

October 18, 2017
A study from Bern University Hospital in collaboration with the University of Bern shows that so-called perivascular-like cells from lung tumors behave abnormally. They not only inadequately support vascular structures, but ...

Many pelvic tumors in women may have common origin—fallopian tubes

October 17, 2017
Most—and possibly all—ovarian cancers start, not in ovaries, but instead in the fallopian tubes attached to them.

Researchers find novel mechanism of resistance to anti-cancer drugs

October 17, 2017
The targeted anti-cancer therapies cetuximab and panitumumab are mainstays of treatment for advanced colorectal cancer, the second leading cause of cancer-related deaths in the United States. However, many patients have tumors ...

New bowel cancer drug target discovered

October 17, 2017
Researchers at the Francis Crick Institute have discovered a new drug target for bowel cancer that is specific to tumour cells and therefore less toxic than conventional therapies.


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.